v3.26.1
Stock-Based Compensation (Summarized Stock Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Outstanding, Number of shares, Beginning Balance     5,866,904 4,918,248 4,918,248  
Granted, Number of shares 0   0      
Exercised 0 (19,331) 0 (36,345)    
Forfeitures, Number of shares       (13,333)    
Outstanding, Number of shares, Ending Balance 5,866,904 5,868,570 5,866,904 5,868,570 5,866,904 4,918,248
Exercisable, Number of Shares 866,904   866,904      
Vested and expected to vest, Number of shares 5,866,904   5,866,904      
Outstanding, Weighted average exercise price, Beginning Balance     $ 8.71 $ 8.70 $ 8.70  
Exercised, Weighted average exercise price       3.02    
Forfeitures, Weighted average exercise price       11.23    
Outstanding, Weighted average exercise price, Ending Balance $ 8.71 $ 8.71 8.71 $ 8.71 $ 8.71 $ 8.70
Exercisable, Weighted average exercise price 3.99   3.99      
Vested and expected to vest, Weighted average exercise price $ 8.71   $ 8.71      
Outstanding, Weighted average remaining contractual term (in years)     2 years 6 months 18 days 3 years 9 months 14 days 3 years 6 months 18 days 4 years 6 months 3 days
Exercisable, Weighted average remaining contractual term (in years)     2 years 11 months 12 days      
Vested and expected to vest, Weighted average remaining contractual term (in years)     2 years 6 months 18 days      
Outstanding, Aggregate intrinsic value, Beginning Balance     $ 703 $ 889 $ 889  
Vested and expecting to vest, Aggregate intrinsic value $ 1,107   1,107      
Exercised, Aggregate intrinsic value       70    
Exercisable, Aggregate intrinsic value 1,107   1,107      
Outstanding, Aggregate intrinsic value, Ending Balance $ 1,107 $ 886 $ 1,107 $ 886 $ 703 $ 889
Outstanding, Weighted average grant date fair value, Beginning Balance     $ 1.20 $ 1.77 $ 1.77  
Forfeitures, Weighted average grant date fair value       8.83    
Outstanding, Weighted average grant date fair value, Ending Balance $ 1.20 $ 1.20 $ 1.20 $ 1.20 $ 1.20 $ 1.77
December 2024 [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, Number of shares       350,000    
Granted, Weighted average exercise price       $ 6.00    
Granted, Aggregate intrinsic value       $ 433    
Granted, Weighted average grant date fair value       $ 1.24    
December 2024 [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, Number of shares       250,000    
Granted, Weighted average exercise price       $ 8.00    
Granted, Aggregate intrinsic value       $ 177    
Granted, Weighted average grant date fair value       $ 0.71    
January 2025 [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, Number of shares       100,000    
Granted, Weighted average exercise price       $ 8.00    
Granted, Weighted average remaining contractual term (in years)       2 years    
Granted, Aggregate intrinsic value       $ 71    
Granted, Weighted average grant date fair value       $ 0.71    
January 2025 [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, Number of shares       150,000    
Granted, Weighted average exercise price       $ 11.00    
Granted, Weighted average remaining contractual term (in years)       2 years    
Granted, Aggregate intrinsic value       $ 107    
Granted, Weighted average grant date fair value       $ 0.71    
January 2025 [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, Number of shares       150,000    
Granted, Weighted average exercise price       $ 14.00    
Granted, Weighted average remaining contractual term (in years)       2 years    
Granted, Aggregate intrinsic value       $ 123    
Granted, Weighted average grant date fair value       $ 0.82